Intraventricular B7-H3 Car T Cells For Diffuse Intrinsic Pontine Glioma: Preliminary First-In-Human Bioactivity And Safety

Vitanza1 N.A., Wilson, A.L., Huang, W., Seidel, K., Brown, C., Gustafson, J.A., Yokoyama, J.K., Johnson, A.J., Baxter, B.A., Koning, R.W., Reid, A.N., Meechan, M., Biery, M.C., Myers, C., Rawlings-Rhea, S.D., Albert, C.M., Browd, S.R., Hauptman, J.S., Lee, A., Ojemann, J.G., Berens, M.E., Dun, M.D., Foster, J.B., Crotty, E.E., Leary, S.E.S., Cole, B.L., Perez, F.A., Wright, J.N., Orentas, R.J., Chour, T., Newell, E.W., Whiteaker, J.R., Zhao, L., Paulovich, A.G., Pinto, N., Gust, J., Gardner, R.A., Jensen, M.C., and Park, J.R. Intraventricular B7-H3 Car T Cells For Diffuse Intrinsic Pontine Glioma: Preliminary First-In-Human Bioactivity And Safety. Cancer Discovery, 2023: 13:114–31. Oct-22.